Securing this partnership required passing months of rigorous due diligence by the Sandoz team. They scrutinised our science, our trial design, our preliminary data, and our team. Their willingness to commit significant resources prior to the availability of Phase III data should provide shareholders with immense confidence.
Everyone on Sandoz team and AVE team except playez is convinced they are on the correct path........Playez has done his own dd but seems reluctant to share this with AVE..........almost like he wants to see AVE fail when he can prevent this from occuring.
onwards and upwards for the believers
AVE Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)